Jump to content
 







Main menu
   


Navigation  



Main page
Contents
Current events
Random article
About Wikipedia
Contact us
Donate
 




Contribute  



Help
Learn to edit
Community portal
Recent changes
Upload file
 








Search  

































Create account

Log in
 









Create account
 Log in
 




Pages for logged out editors learn more  



Contributions
Talk
 



















Contents

   



(Top)
 


1 FDA category B or C  
3 comments  




2 Misuse Section  
2 comments  




3 Use section  
1 comment  




4 Footnote 17 is a broken link, please fix  





5 External links modified  
1 comment  




6 eosinophilic oesophagitis  
1 comment  




7 Pharmacokinetics section  
1 comment  




8 Wiki Education assignment: PHMD 2040 Service - Learning Spring 2024  
1 comment  













Talk:Budesonide




Page contents not supported in other languages.  









Article
Talk
 

















Read
Edit
Add topic
View history
 








Tools
   


Actions  



Read
Edit
Add topic
View history
 




General  



What links here
Related changes
Upload file
Special pages
Permanent link
Page information
Get shortened URL
Download QR code
 




Print/export  



Download as PDF
Printable version
 
















Appearance
   

 






From Wikipedia, the free encyclopedia
 


FDA category B or C[edit]

I've found conflicting reports of the FDA pregnancy category for this drug. Please see reference: http://www.rxlist.com/cgi/generic/budesonide_wcp.htm

Thank you —Preceding unsigned comment added by 76.177.33.33 (talk) 22:36, 9 September 2007 (UTC)[reply]

The FDA drug label information says that it is Category C, so at least the budesonide formulation sold by GlaxoSmithKline is class C. Pgk1 00:18, 18 October 2007 (UTC)[reply]

I just did some research on this today. According to this FDA report it is pregnancy class B for the nasal inhalant form: http://www.accessdata.fda.gov/drugsatfda_docs/label/2008/021949s004lbl.pdf — Preceding unsigned comment added by 98.192.147.255 (talk) 17:12, 10 October 2011 (UTC)[reply]

Misuse Section[edit]

The misuse section seems to be more about misuse of Medicare/Insurance fraud than misuse of this particular product. Maybe it should be removed? Or re-labelled "In the news" or something. — Preceding unsigned comment added by 124.148.172.201 (talk) 08:50, 11 April 2012 (UTC)[reply]

I don't think it's important enough to meet WP:WEIGHT or keep in the article. Does anybody have a reason to keep it in? --Nbauman (talk) 06:15, 4 September 2012 (UTC)[reply]

Use section[edit]

The 'Use' section does not mention the fact that the drug is also used to treat rhinitis even though this is clearly mentioned in the introductory paragraph of the article. — Preceding unsigned comment added by Belnac (talkcontribs) 10:15, 6 November 2013 (UTC)[reply]

Footnote 17 is a broken link, please fix[edit]

External links modified[edit]

Hello fellow Wikipedians,

I have just modified 2 external links on Budesonide. Please take a moment to review my edit. If you have any questions, or need the bot to ignore the links, or the page altogether, please visit this simple FaQ for additional information. I made the following changes:

When you have finished reviewing my changes, please set the checked parameter below to trueorfailed to let others know (documentation at {{Sourcecheck}}).

This message was posted before February 2018. After February 2018, "External links modified" talk page sections are no longer generated or monitored by InternetArchiveBot. No special action is required regarding these talk page notices, other than regular verification using the archive tool instructions below. Editors have permission to delete these "External links modified" talk page sections if they want to de-clutter talk pages, but see the RfC before doing mass systematic removals. This message is updated dynamically through the template {{source check}} (last update: 5 June 2024).

Cheers.—InternetArchiveBot (Report bug) 08:05, 10 November 2016 (UTC)[reply]

eosinophilic oesophagitis[edit]

I am not a wikipedia editor. Maybe you want to add informations about eosinophilic oesophagitis and Jorveza.

https://en.wikipedia.org/wiki/Eosinophilic_esophagitis

https://www.ema.europa.eu/en/medicines/human/EPAR/jorveza

https://www.medicines.org.uk/emc/product/9446/smpc

https://www.drfalkpharma-benelux.eu/sites/www.drfalkpharma-benelux.nl/files/01-2018-BNL%20Press%20release%20Jorveza.pdf — Preceding unsigned comment added by 37.49.65.123 (talk) 09:07, 1 June 2019 (UTC)[reply]

Pharmacokinetics section[edit]

In this section we have

"Distribution: 2.2-3.9 L/kg"

What is that actually supposed to say? John G Hasler (talk) 23:15, 9 July 2021 (UTC)[reply]

Wiki Education assignment: PHMD 2040 Service - Learning Spring 2024[edit]

This article was the subject of a Wiki Education Foundation-supported course assignment, between 8 January 2024 and 31 May 2024. Further details are available on the course page. Student editor(s): Benadryl Submarine (article contribs).

— Assignment last updated by Benadryl Submarine (talk) 07:04, 28 April 2024 (UTC)[reply]


Retrieved from "https://en.wikipedia.org/w/index.php?title=Talk:Budesonide&oldid=1221160264"

Categories: 
C-Class pharmacology articles
Mid-importance pharmacology articles
WikiProject Pharmacology articles
C-Class medicine articles
Mid-importance medicine articles
C-Class WikiProject Medicine Translation Task Force articles
High-importance WikiProject Medicine Translation Task Force articles
WikiProject Medicine Translation Task Force articles
All WikiProject Medicine pages
C-Class COVID-19 articles
Low-importance COVID-19 articles
WikiProject COVID-19 articles
Hidden category: 
Wikipedia pages about contentious topics
 



This page was last edited on 28 April 2024, at 07:04 (UTC).

Text is available under the Creative Commons Attribution-ShareAlike License 4.0; additional terms may apply. By using this site, you agree to the Terms of Use and Privacy Policy. Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc., a non-profit organization.



Privacy policy

About Wikipedia

Disclaimers

Contact Wikipedia

Code of Conduct

Developers

Statistics

Cookie statement

Mobile view



Wikimedia Foundation
Powered by MediaWiki